SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-444189
Filing Date
2013-11-18
Accepted
2013-11-15 18:30:36
Documents
4
Period of Report
2013-11-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d631284d8k.htm 8-K 14761
2 EX-99.1 d631284dex991.htm EX-99.1 8601
3 GRAPHIC g631284001.jpg GRAPHIC 9574
4 GRAPHIC g631284002.jpg GRAPHIC 4011
  Complete submission text file 0001193125-13-444189.txt   43686
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 131225023
SIC: 2834 Pharmaceutical Preparations